BRCA mutation carriers do not have compromised ovarian reserve

International Journal of Gynecological Cancer

Volumn 24, Issue 2, 2014, Pages 233-237

  Michaelson Cohen, Rachel ^a   Mor, Pnina ^a   Srebnik, Naama ^a   Beller, Uziel ^a   Levy Lahad, Ephrat ^a   Eldar Geva, Talia ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Anti m llerian hormone; BRCA1 2 mutation carriers; Ovarian reserve

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; ASHKENAZI JEWISH FOUNDER MUTATION; CANCER CENTER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILITY; GENE MUTATION; HORMONE BLOOD LEVEL; HUMAN; NORMAL HUMAN; OVARIAN RESERVE; OVARY POLYCYSTIC DISEASE; PARITY; PILOT STUDY; PRIORITY JOURNAL;

ADULT; ANTI-MULLERIAN HORMONE; CARRIER STATE; FEMALE; FERTILITY; GENES, BRCA1; GENES, BRCA2; GENETIC MARKERS; HETEROZYGOTE DETECTION; HUMANS; OVARY; PILOT PROJECTS;

EID: 84893739814     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000058     Document Type: Article

References (20)

1. Lansdorp PM. Repair of telomeric DNA prior to replicative senescence. Mech Ageing Dev. 2000;118:23-34.
2. McPherson JP, Hande MP, Poonepalli A, et al. A role for BRCA1 in chromosome end maintenance. Hum Mol Genet. 2006;15:831-838.
3. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995;57:1457-1462.
4. Oktay K, Kim JY, Barad D, et al. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol. 2010;28:240-244.
5. Moslehi R, Singh R, Lessner L, et al. Impact of BRCA mutations on female fertility and offspring sex ratio. Am J Hum Biol. 2010;22:201-205.
6. Pal T, Keefe D, Sun P, et al. Fertility in women with BRCA mutations: a case-control study. Fertil Steril. 2010;93: 1805-1808.
7. Kotsopoulos J, Librach CL, Lubinski J, et al. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study. Cancer Causes Control. 2008;19:1111-1119.
8. Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 8th ed. Lippicont Williams & Wilkins, Baltimore, MD; 2011.
9. Rajpert-De Meyts E, Jorgensen N, Graem N, et al. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab. 1999; 84:3836-3844.
10. van Rooij IA, Broekmans FJ, te Velde ER, et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065-3071.
11. Laven JS, Mulders AG, Visser JA, et al. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89:318-323.
12. Broer SL, Eijkemans MJ, Scheffer GJ, et al. Anti-müllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96: 2532-2539.
13. Kwee J, Schats R, McDonnell J, et al. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertil Steril. 2008;90:737-743.
14. Broer SL, van Disseldorp J, Broeze KA, et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26-36.
15. Titus S, Li F, Stobezki R, et al. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med. 2013;5:172ra21.
16. Nelson SM, Messow MC, Wallace AM, et al. Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients. Fertil Steril. 2011; 95:736-741 e1-e3.
17. AlmogB, Shehata F, Suissa S, et al.Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril. 2011;95:2359-2363, 2363 e1.
18. Eitan R, Michaelson-Cohen R, Levavi H, et al. The counseling and management of young healthy BRCA mutation carriers. Int J Gynecol Cancer. 2009;19:1156-1159.
19. Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002;346:1616-1622.
20. Samuel JC, Ollila DW. Prophylaxis and screening options: recommendations for young women with BRCA mutations. Breast Dis. 2005;23:31-35.